Title:
アジュバント癌治療の方法
Document Type and Number:
Japanese Patent JP6684941
Kind Code:
B2
Abstract:
The present invention provides a method of providing adjuvant treatment to a human patient which comprises administering to such a patient therapeutically effective doses of dabrafenib and trametinib for a time period sufficient to increase relapse-free survival (RFS).
Inventors:
Raquere, Sylvie
Levowitz, Peter F.
Levowitz, Peter F.
Application Number:
JP2019072361A
Publication Date:
April 22, 2020
Filing Date:
April 05, 2019
Export Citation:
Assignee:
Novartis Age
International Classes:
A61K31/506; A61K31/519; A61P17/00; A61P35/00; A61P43/00
Foreign References:
| WO2011047238A1 | ||||
| WO2012095505A1 |
Other References:
Journal of Translational Medicine,2012年 5月,10(85),p.1-9
Attorney, Agent or Firm:
Yusuke Hiraki
Satoshi Fujita
Natsuo Tanaka
Naoko Kikuta
Satoshi Fujita
Natsuo Tanaka
Naoko Kikuta